Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
049
|
Date of Entry 06/07/2018
|
FR Recognition Number
|
4-240
|
Standard | |
ISO 21563 First edition 2013-08-15 Dentistry - Hydrocolloid impression materials |
|
Identical AdoptionANSI ADA Standard No. 128-2015 Hydrocolloid Impression Materials |
|
Scope/AbstractThis International Standard specifies the requirements and tests for helping determine whether the elastic aqueous agar and alginate hydrocolloid dental impression materials, as prepared for retail marketing, are of the quality needed for their intended purposes. It also specifies requirements for labelling and instructions for use.
NOTE This International Standard specifies no requirements or tests for freedom from unacceptable biological hazards. However, it is recommended that, to address possible biological hazards associated with the use of hydrocolloid impression materials, interested parties should refer to ISO 7405 and ISO 10993.
|
|
Extent of Recognition
|
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies. |
|
Transition Period
FDA recognition of ISO 21563 First edition 2013-08 [Rec# 4-240] will be superseded by recognition of ISO 21563 Second edition 2021-08 [Rec# 4-301]. FDA will accept declarations of conformity, in support of premarket submissions, to [Rec# 4-240] until July 6, 2025. After this transition period, declarations of conformity to [Rec# 4-240] will not be accepted. |
|
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number |
Device Name |
Device Class |
Product Code |
§872.3660 |
Material, Impression
|
Class 2
|
ELW
|
§872.3760 |
Resin, Denture, Relining, Repairing, Rebasing
|
Class 2
|
EBI
|
|
Relevant FDA Guidance and/or Supportive Publications*
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contacts
|
Standards Development Organization
|
FDA Specialty Task Group (STG)
|
*These are provided as examples and others may be applicable. |